SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-184014
Filing Date
2020-06-30
Accepted
2020-06-30 16:07:40
Documents
4
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d913987d6k.htm 6-K 9349
2 EX-99.1 d913987dex991.htm EX-99.1 12635
3 EX-99.2 d913987dex992.htm EX-99.2 18334
4 EX-99.3 d913987dex993.htm EX-99.3 13427
  Complete submission text file 0001193125-20-184014.txt   54769
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 201002396
SIC: 2834 Pharmaceutical Preparations